Lesson 1Dose-response, routes of administration, pharmacokinetics and detection windows relevant to clinical decisionsWe cover how dose affects response, pills versus injections, choosing esters, liver effects first time through, and how the body handles the drugs. It includes half-life, active byproducts, build-up, and time to detect in tests for doctor care.
Dose–response curves and ceiling anabolic effectsOral versus injectable formulations and bioavailabilityEster length, depot kinetics, and dosing intervalsHepatic metabolism, active metabolites, and clearanceSteady state, accumulation, and washout timelinesDetection windows and anti-doping test strategiesLesson 2Interactions with other medications and common comorbidities affecting choice and safetyWe check drug clashes and sickness effects that change safety of these agents, like with blood thinners, sugar diabetes meds, blood pressure pills, liver kidney problems, sleep stopping breathing, and heart prostate dangers.
Interactions with anticoagulants and antiplatelet drugsEffects on insulin, oral hypoglycemics, and glycemiaBlood pressure, diuretics, and cardiovascular therapiesHepatic and renal impairment considerationsSleep apnea, obesity, and cardiometabolic riskProstate disease, breast cancer, and hormone-sensitive tumorsLesson 3Classification of anabolic agents: testosterone esters, nandrolone, oxandrolone, stanozolol, selective androgen receptor modulators (SARMs) and precursorsWe group big anabolic drugs like testosterone esters, 19-nor types, DHT mouth pills, SARMs, and starters. We talk structure power links, strength, body part pick, and usual doctor or street uses.
Testosterone esters and their clinical applicationsNandrolone and other 19-nor anabolic derivativesDHT-based orals such as stanozolol and oxandroloneSelective androgen receptor modulators in developmentProhormones and over-the-counter precursorsStructure–activity links to anabolic and androgenic effectsLesson 4Guidelines and position statements: Endocrine Society, American Thoracic Society, FDA/EMA drug labels, and specialty society recommendations for anabolic useWe sum up key rules and official stands on anabolic treatment from Endocrine Society, lung doctors group, FDA EMA labels. We point out test levels, no-go cases, watching, and dose plans.
Endocrine Society guidance on testosterone therapyATS and pulmonary society views on wasting in COPDFDA and EMA labeling for key anabolic agentsContraindications and boxed warnings in guidelinesRecommended monitoring and follow-up intervalsReconciling conflicting expert recommendationsLesson 5Alternatives to anabolic agents for wasting or performance goals: nutrition, resistance training, protein supplementation, and non-androgenic pharmacotherapiesWe look at non-hormone ways to fight wasting and boost performance, stressing good food plans, weight lifting, protein creatine adds, and extra meds that build lean body with less hormone danger.
Energy and protein targets in catabolic conditionsPeriodized resistance training for lean mass gainProtein, leucine, and HMB supplementation strategiesCreatine, beta-alanine, and ergogenic nutrition aidsAppetite stimulants and anabolic non-androgen drugsChoosing alternatives when androgens are unsuitableLesson 6Off-label uses and evidence base: anabolic use in sarcopenia, frailty, anorexia nervosa-related wasting, and athletic performance claimsWe check off-label anabolic in muscle loss old age, weakness, eating disorder wasting, sports claims. We stress study facts, effect strength, safety warnings, why many uses still trial or not advised.
Testosterone in age-related sarcopenia and frailtyAnabolic agents in anorexia nervosa and severe dietingNandrolone and others in chronic illness–related wastingEvidence and ethics in athletic performance enhancementRisk–benefit profile of off-label anabolic regimensRegulatory and medico-legal considerationsLesson 7Monitoring parameters during therapeutic anabolic use: labs, imaging, functional outcomes, and timelines for expected benefitWe set proof-based watching in anabolic treatment, with start risk check, blood tests, scans, function tests. We map times for gains, bad effects, rules for dose shift or stop.
Baseline evaluation and informed consent processLaboratory panels for safety and efficacy trackingImaging and body composition assessment toolsFunctional outcomes and quality-of-life measuresTimelines for benefit onset and plateau effectsCriteria for dose adjustment or discontinuationLesson 8Androgen physiology: endogenous testosterone synthesis, AR signaling, and metabolic effectsWe go over normal male hormone body work, brain gland control, testicle adrenal making, receptor signals, effects on muscle bone blood cells sugar burn.
Hypothalamic–pituitary–gonadal axis regulationTesticular and adrenal androgen synthesis pathwaysAndrogen receptor structure and signaling cascadesGenomic versus non-genomic androgen actionsEffects on muscle, bone, and erythropoiesisImpacts on lipids, insulin sensitivity, and fatLesson 9Approved medical indications: hypogonadism, cachexia, severe burn/trauma, HIV-associated wasting, select COPD and chronic disease contextsWe review proof okay uses for anabolic drugs, on test low, wasting sickness, bad burns injury, HIV thinness, lung COPD long sickness, with test rules dose risk good balance.
Diagnostic criteria for hypogonadism and treatment thresholdsAnabolic use in cancer cachexia and chronic disease wastingOxandrolone in severe burn and major trauma recoveryTestosterone and analogs in HIV-associated wastingUse in COPD and advanced cardiopulmonary diseaseBalancing benefit, contraindications, and adverse risks
